Stocks to Buy on Do...
Health Care: Drugs
Vanda Pharmaceuticals Inc. (VNDA: NASDAQ)
$5.28 0.02 | 0.38%
02/08/12 - 04:00 PM ET
104.29K / 207.60K
Vol / Avg. Vol:5.28 / 5.26
Open / Prev. Close:5.20 - 5.36
Today's Range:4.33 - 8.45
52 Wk Range:10.50%
Performance YTD:TheStreet Rating:
Portfolios with VNDA
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- UserWatching
- Contributor10 Unloved Stocks to Rise U...
- Contributor10 Companies That Missed Ea...
- UserJim Luterek Portfolio 1
- Userjph1020 Portfolio 1
- UserHot Biotech Stocks
- Userbigboyjohno Portfolio 1
- UserLatest Activist Filings 2-2...
- ContributorBarron's Activist Stocks 2-...
Latest VNDA Headlines from TheStreet
- Vanda Pharmaceuticals Inc. Stock Downgraded (VNDA) 11.08.11 | 05:11 am
- Biotech Stock Mailbag: Exelixis 10.28.11 | 06:10 am
- 5 Stocks Setting Up to Break Out 04.18.11 | 07:04 am
- Biotech Stock Mailbag: Bio-Hazards 03.25.11 | 07:03 am
- Vanda Pharmaceuticals Inc. Stock Upgraded By TheStreet Ratings (VNDA) 02.11.11 | 05:02 pm
- Vanda's Fanapt Falls Flat 02.04.11 | 11:02 am
- Clinical Data: Bulls and Bears Round Two 01.25.11 | 06:01 am
- 10 Unloved Stocks to Rise Up to 120% 12.16.10 | 06:12 am
- Biotech Stock Mailbag - Titan Pharma 10.22.10 | 08:10 am
- Biotech Stock Mailbag: Exact Sciences 10.15.10 | 07:10 am
Press Releases for VNDA
- Initial Clinical Data Reveal Potential Of Tasimelteon To Reset The Body Clock In Non-24-Hour Sleep-Wake Disorder - PR Newswire 01.26.12 | 07:01 am
- Vanda Pharmaceuticals Enters Into An Exclusive License Agreement With Megapharm Ltd. For Commercialization Of Fanapt⢠In Israel - PR Newswire 12.13.11 | 07:12 am
- Vanda Pharmaceuticals Appoints Chief Commercial Officer - PR Newswire 10.24.11 | 05:10 pm
- Vanda Pharmaceuticals To Announce Third Quarter 2011 Financial Results On November 4, 2011 - PR Newswire 10.18.11 | 07:10 pm
- Vanda Pharmaceuticals To Participate In UBS Global Life Sciences Conference - PR Newswire 09.14.11 | 07:09 pm
- Vanda Pharmaceuticals To Participate In Stifel Nicolaus Global Healthcare Conference And Jefferies Fall 2011 Mid-Atlantic Corporate Access Day - PR Newswire 08.31.11 | 07:08 pm
- Vanda Pharmaceuticals Enters Into An Exclusive License Agreement With Biotoscana Farma S.A. For Commercialization Of Fanapt ¢ In Argentina. - PR Newswire 08.01.11 | 07:08 am
- European Medicines Agency Accepts Vanda Pharmaceuticals Inc.'s Marketing Authorization Application For Oral Iloperidone Tablets - PR Newswire 07.26.11 | 07:07 am
- Vanda Pharmaceuticals To Announce Second Quarter 2011 Financial Results On August 4, 2011 - PR Newswire 07.20.11 | 03:07 pm
- Vanda Pharmaceuticals Enters Into An Exclusive License Agreement With Probiomed S.A. De C.V. For Commercialization Of Fanapt⢠In Mexico - PR Newswire 07.11.11 | 07:07 am
Partner Headlines for VNDA
- Healthcare Stocks To Watch This Week - Seeking Alpha 10.12.11 | 08:10 am
- 6 Deeply Undervalued Biotech Stocks - Seeking Alpha 07.27.11 | 09:07 am
- What FDA's Delay of Probuphine Trial Means for Titan Pharmaceuticals - Seeking Alpha 06.20.11 | 08:06 am
- As the Market Dips, It's Time to Look for Biotech Sector Deals - Seeking Alpha 06.12.11 | 09:06 am
- Titan Pharmaceuticals: $2 Mark Broken - Looks to Hold - Seeking Alpha 05.26.11 | 09:05 am
- 6 Cash Rich Biotech Stocks With Catalysts - Seeking Alpha 04.08.11 | 08:04 am
- UPDATE 2-US FDA chemist, son charged with insider trading - Reuters 03.29.11 | 05:03 pm
- Hapoalim Securities Lowers VNDA Target To $15 From $16 - Benzinga 02.07.11 | 09:02 am
- UPDATE 1-Vanda gets positive ruling from IRS, shares soar - Reuters 11.15.10 | 11:11 am
- Vanda's Pipeline Progresses - Analyst Blog - Zacks 08.27.10 | 06:08 pm
